Chapter 5. Epidemiology, Etiology, and Natural History of Hepatocellular Carcinoma

  1. Pierre-Alain Clavien MD, Phd, FACS, FRCS Professor Chairman and
  2. Stefan Breitenstein MD
  1. Wei-Chen Lee MD and
  2. Miin-Fu Chen MD, FACS

Published Online: 9 DEC 2009

DOI: 10.1002/9781444317053.ch5

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

Malignant Liver Tumors: Current and Emerging Therapies, Third Edition

How to Cite

Lee, W.-C. and Chen, M.-F. (2010) Epidemiology, Etiology, and Natural History of Hepatocellular Carcinoma, in Malignant Liver Tumors: Current and Emerging Therapies, Third Edition (eds P.-A. Clavien and S. Breitenstein), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781444317053.ch5

Editor Information

  1. Department of Surgery, Swiss Hepato-Pancreato-Biliary and Transplantation Center, University Hospital Zurich, Zurich, Switzerland

Author Information

  1. Chang-Gung Memorial Hospital, Chang-Gung University Medical School, Taoyuan, Taiwan

Publication History

  1. Published Online: 9 DEC 2009
  2. Published Print: 12 JAN 2010

ISBN Information

Print ISBN: 9781405179768

Online ISBN: 9781444317053

SEARCH

Keywords:

  • epidemiology, etiology, and natural history of hepatocellular carcinoma;
  • malignant liver tumor - fifth common cancer in the world and third, cause of cancer mortality;
  • Hepatitis C virus infection - cause of chronic liver diseases;
  • cirrhosis, common late-stage development of liver diseases;
  • obesity, significant risk factor for development of HCC;
  • hemochromatosis - hereditary hemochromatosis or iron overload disorder;
  • HCC in cirrhotic livers or livers with underlying diseases

Summary

This chapter contains sections titled:

  • Epidemiology

  • Etiology

  • Self-assessment questions

  • Natural history of HCC

  • References

  • Self-assessment answers